Viewing Study NCT05663827


Ignite Creation Date: 2025-12-25 @ 5:06 AM
Ignite Modification Date: 2025-12-26 @ 4:10 AM
Study NCT ID: NCT05663827
Status: COMPLETED
Last Update Posted: 2024-03-05
First Post: 2022-11-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Ruxolitinib as add-on Therapy in Steroid-refractory Graft-vs-host Disease
Sponsor: Yi-Lun Wang
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module